Goutman, Stephen A. http://orcid.org/0000-0001-8780-6637
Savelieff, Masha G. http://orcid.org/0000-0001-5575-2494
Jang, Dae-Gyu
Hur, Junguk http://orcid.org/0000-0002-0736-2149
Feldman, Eva L. http://orcid.org/0000-0002-9162-2694
Article History
Accepted: 8 August 2023
First Online: 14 September 2023
Competing interests
: S.A.G., D.-G.J. and E.L.F. are employees of the University of Michigan. M.G.S. and J.H. are employees of the University of North Dakota. S.A.G. and E.L.F. are listed as inventors on a patent, issue number US10660895, held by the University of Michigan, entitled ‘Methods for treating amyotrophic lateral sclerosis’ that targets immune pathways for use in amyotrophic lateral sclerosis (ALS) therapeutics. S.A.G. has served on a Data and Safety Monitoring Board and as a medical adviser for an ALS documentary. E.L.F. has consulted for Biogen.